216 related articles for article (PubMed ID: 24648112)
21. Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling.
Zhang X; Lu H; Hong W; Liu L; Wang S; Zhou M; Chen B; Bai Y
Oncol Rep; 2018 Apr; 39(4):1892-1900. PubMed ID: 29393444
[TBL] [Abstract][Full Text] [Related]
22. Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?
Jaśkiewicz A; Domoradzki T; Pająk B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158194
[TBL] [Abstract][Full Text] [Related]
23. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury.
Yang Y; Duan W; Jin Z; Yi W; Yan J; Zhang S; Wang N; Liang Z; Li Y; Chen W; Yi D; Yu S
J Pineal Res; 2013 Oct; 55(3):275-86. PubMed ID: 23796350
[TBL] [Abstract][Full Text] [Related]
24. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
[TBL] [Abstract][Full Text] [Related]
25. JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells.
Park JS; Lee J; Lim MA; Kim EK; Kim SM; Ryu JG; Lee JH; Kwok SK; Park KS; Kim HY; Park SH; Cho ML
J Immunol; 2014 May; 192(9):4417-24. PubMed ID: 24688026
[TBL] [Abstract][Full Text] [Related]
26. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells.
Yu JH; Kim KH; Kim H
Biochem Pharmacol; 2006 Nov; 72(11):1555-62. PubMed ID: 16934228
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a cancer cachectic factor.
Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
[TBL] [Abstract][Full Text] [Related]
28. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
[TBL] [Abstract][Full Text] [Related]
29. A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination.
Kapuria V; Levitzki A; Bornmann WG; Maxwell D; Priebe W; Sorenson RJ; Showalter HD; Talpaz M; Donato NJ
Cell Signal; 2011 Dec; 23(12):2076-85. PubMed ID: 21855629
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats.
Wang D; Yin J; Dong R; Zhao J; Wang Q; Wang N; Wang S; Du X; Lu J
Dig Liver Dis; 2015 Apr; 47(4):315-23. PubMed ID: 25637451
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Janus kinase 2 and signal transduction and activator of transcription 3 protect against cecal ligation and puncture-induced multiple organ damage and mortality.
Hui L; Yao Y; Wang S; Yu Y; Dong N; Li H; Sheng Z
J Trauma; 2009 Mar; 66(3):859-65. PubMed ID: 19276765
[TBL] [Abstract][Full Text] [Related]
32. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
33. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
[TBL] [Abstract][Full Text] [Related]
34. Novel black soy peptides with antiobesity effects: activation of leptin-like signaling and AMP-activated protein kinase.
Jang EH; Moon JS; Ko JH; Ahn CW; Lee HH; Shin JK; Park CS; Kang JH
Int J Obes (Lond); 2008 Jul; 32(7):1161-70. PubMed ID: 18414417
[TBL] [Abstract][Full Text] [Related]
35. JAK2-STAT3 signaling pathway mediates thrombin-induced proinflammatory actions of microglia in vitro.
Huang C; Ma R; Sun S; Wei G; Fang Y; Liu R; Li G
J Neuroimmunol; 2008 Nov; 204(1-2):118-25. PubMed ID: 18710787
[TBL] [Abstract][Full Text] [Related]
36. PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model.
Yun HM; Park KR; Park MH; Kim DH; Jo MR; Kim JY; Kim EC; Yoon DY; Han SB; Hong JT
Free Radic Biol Med; 2015 Mar; 80():136-44. PubMed ID: 25582888
[TBL] [Abstract][Full Text] [Related]
37. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
38. Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.
Narsale AA; Puppa MJ; Hardee JP; VanderVeen BN; Enos RT; Murphy EA; Carson JA
Oncotarget; 2016 Sep; 7(37):59482-59502. PubMed ID: 27449092
[TBL] [Abstract][Full Text] [Related]
39. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
Tong H; Ren Y; Zhang F; Jin J
Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
[TBL] [Abstract][Full Text] [Related]
40. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
